Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca

NCT01074814 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Approved therapy will be assigned based on molecular profile and RPMA results

Sponsor

Translational Drug Development

Collaborators

[object Object]